Cognitive Assessment for Liver Surgery Patients

Overseen By Timothy Newhook, MD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: M.D. Anderson Cancer Center

Disqualifiers: Non-English speakers, Cognitive impairment, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 2

100 Participants Needed

Trial Summary

What is the purpose of this trial?

This trial studies how well electronic neurocognitive tools work in screening for mental capability in patients who are undergoing liver surgery. Using electronic neurocognitive screening tools may help to better assess mental impairment.

Research Team

Timothy Newhook, MD

Principal Investigator

M.D. Anderson Cancer Center

Eligibility Criteria

This trial is for English-speaking patients at UT-MD Anderson Cancer Center who are about to have liver surgery and can give informed consent. It's designed to see if they're mentally sharp enough for the procedure.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-Surgery Assessment

Participants receive cognitive assessments (BrainCheck and paper and pen) 2 months prior to surgery

2 months

1 visit (in-person)

Post-Surgery Assessment

Participants receive cognitive assessments (BrainCheck and paper and pen) within 2 months after surgery

2 months

1 visit (in-person)

Follow-up

Participants are monitored for cognitive assessment outcomes up to 1 year

Up to 1 year

Treatment Details

Interventions

• BrainCheck Cognitive Assessment
• Cognitive Assessment

Trial Overview The study is testing electronic tools called BrainCheck Cognitive Assessment to screen mental capability in patients before liver surgery, aiming to identify any cognitive impairments more effectively.

Participant Groups

Group I: Group I (BrainCheck and paper and pen cognitive assessment) Experimental Treatment 2 Interventions

Patients receive the BrainCheck cognitive assessment over 15 minutes followed by the paper and pen assessment 2 months prior to surgery and within 2 months after surgery.

Group II: Group II (pen and paper and BrainCheck cognitive assessment) Active Control 2 Interventions

Patients receive the paper and pen assessment followed by the BrainCheck cognitive assessment over 15 minutes 2 months prior to surgery and within 2 months after surgery.

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials

3,107

Recruited

1,813,000+

National Cancer Institute (NCI)

Collaborator

Trials

14,080

Recruited

41,180,000+